Article info
PDFLetter
Infliximab as a treatment for systemic amyloidosis associated with Crohn’s disease
- Correspondence to:
Dr M Iizuka
Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan; maiizuka{at}doc.med.akita-u.ac.jp
Citation
Infliximab as a treatment for systemic amyloidosis associated with Crohn’s disease
Publication history
- First published April 11, 2006.
Online issue publication
January 09, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Gut